PemToxTrial: An Observational Study of PEMetrexed-Associated Severe HematoTOXicity in Lung Adenocarcinoma with Bone Metastases
There is currently no evidence regarding the extent to which bone metastases affect the incidence of side effects during pemetrexed therapy, and patients with lung adenocarcinoma might benefit from a treatment regimen without pemetrexed or from closer monitoring during therapy, in line with a personalized treatment app...